SPPAM
CLBT icon

Summit Partners Public Asset Management’s Cellebrite CLBT Stock Holding History

Summit Partners Public Asset Management’s Portfolio CLBT Stock Details CLBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-542,138
Closed -$11.9M – 153
2024
Q4 		$11.9M Sell
542,138
-8,599
-2% -$166K 0.23% 103
2024
Q3 		$9.27M Buy
+550,737
New +$8.17M 0.29% 77

Other funds holding CLBT

TWCM
True Wind Capital Management San Francisco, California $226M AUM 2.79% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AE
Axon Enterprise Scottsdale, Arizona $19.1M AUM 8.75% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
VC
Voss Capital Houston, Texas $2.15B AUM 33.46% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Summit Partners Public Asset Management's CLBT Position: Q1 2025 in Review

Summit Partners Public Asset Management sold out of Cellebrite (CLBT) in Q1 2025, closing a stake of 542,138 shares — an estimated $11.9M sold.

Summit Partners Public Asset Management first reported a position in CLBT in Q3 2024 and held it in 2 quarters. The position peaked at $11.9M in Q4 2024. 199 funds tracked by Wall St. Rank hold CLBT as of Q1 2025.

  • Summit Partners Public Asset Management reported no remaining Cellebrite position as of Q1 2025 after selling out during the quarter.
  • Summit Partners Public Asset Management sold 542,138 Cellebrite shares in Q1 2025, an estimated $11.9M.
  • Summit Partners Public Asset Management first reported a position in Cellebrite in Q3 2024 and held it in 2 quarters.
  • Summit Partners Public Asset Management's Cellebrite position peaked at $11.9M in Q4 2024.
  • 199 funds tracked by Wall St. Rank held Cellebrite as of Q1 2025.

Based on Summit Partners Public Asset Management's 13F filing for Q1 2025, filed 15 May 2025.